124 related articles for article (PubMed ID: 8631919)
1. Phosphorylation-independent stimulation of DNA topoisomerase II alpha activity.
Kimura K; Saijo M; Tanaka M; Enomoto T
J Biol Chem; 1996 May; 271(18):10990-5. PubMed ID: 8631919
[TBL] [Abstract][Full Text] [Related]
2. Casein kinase II stabilizes the activity of human topoisomerase IIalpha in a phosphorylation-independent manner.
Redwood C; Davies SL; Wells NJ; Fry AM; Hickson ID
J Biol Chem; 1998 Feb; 273(6):3635-42. PubMed ID: 9452492
[TBL] [Abstract][Full Text] [Related]
3. Retinoic acid and phorbol ester induced hyperphosphorylation of topoisomerase II-alpha is an early event in HL-60 human leukaemia cell differentiation: effect on topoisomerase activity and etoposide sensitivity.
Chresta CM; Hall BF; Francis GE
Leukemia; 1995 Aug; 9(8):1373-81. PubMed ID: 7643627
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.
Chikamori K; Grabowski DR; Kinter M; Willard BB; Yadav S; Aebersold RH; Bukowski RM; Hickson ID; Andersen AH; Ganapathi R; Ganapathi MK
J Biol Chem; 2003 Apr; 278(15):12696-702. PubMed ID: 12569090
[TBL] [Abstract][Full Text] [Related]
5. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
Chen G; Templeton D; Suttle DP; Stacey DW
Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha.
Aoyama M; Grabowski DR; Dubyak GR; Constantinou AI; Rybicki LA; Bukowski RM; Ganapathi MK; Hickson ID; Ganapathi R
Biochem J; 1998 Dec; 336 ( Pt 3)(Pt 3):727-33. PubMed ID: 9841887
[TBL] [Abstract][Full Text] [Related]
7. Mitotic phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the MPM-2 phosphoepitope on Ser-1469.
Escargueil AE; Plisov SY; Filhol O; Cochet C; Larsen AK
J Biol Chem; 2000 Nov; 275(44):34710-8. PubMed ID: 10942766
[TBL] [Abstract][Full Text] [Related]
8. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin.
Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M
Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812
[TBL] [Abstract][Full Text] [Related]
9. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
Grozav AG; Chikamori K; Kozuki T; Grabowski DR; Bukowski RM; Willard B; Kinter M; Andersen AH; Ganapathi R; Ganapathi MK
Nucleic Acids Res; 2009 Feb; 37(2):382-92. PubMed ID: 19043076
[TBL] [Abstract][Full Text] [Related]
10. A casein kinase type II (CKII)-like nuclear protein kinase associates with, phosphorylates, and activates topoisomerase I.
Turman MA; Douvas A
Biochem Med Metab Biol; 1993 Oct; 50(2):210-25. PubMed ID: 8260198
[TBL] [Abstract][Full Text] [Related]
11. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation.
Constantinou AI; Vaughan AT; Yamasaki H; Kamath N
Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591
[TBL] [Abstract][Full Text] [Related]
12. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
Gromova I; Biersack H; Jensen S; Nielsen OF; Westergaard O; Andersen AH
Biochemistry; 1998 Nov; 37(47):16645-52. PubMed ID: 9843432
[TBL] [Abstract][Full Text] [Related]
13. Treatment of U937 cells with bufalin induces the translocation of casein kinase 2 and modulates the activity of topoisomerase II prior to the induction of apoptosis.
Watabe M; Nakajo S; Yoshida T; Kuroiwa Y; Nakaya K
Cell Growth Differ; 1997 Aug; 8(8):871-9. PubMed ID: 9269896
[TBL] [Abstract][Full Text] [Related]
14. Topoisomerase II activities in AML and their correlation with cellular sensitivity to anthracyclines and epipodophyllotoxines.
Gieseler F; Glasmacher A; Kämpfe D; Wandt H; Nuessler V; Valsamas S; Kunze J; Wilms K
Leukemia; 1996 Jul; 10(7):1177-80. PubMed ID: 8683999
[TBL] [Abstract][Full Text] [Related]
15. Casein kinase II-dependent phosphorylation of DNA topoisomerase II suppresses the effect of a catalytic topo II inhibitor, ICRF-193, in fission yeast.
Nakazawa N; Arakawa O; Ebe M; Yanagida M
J Biol Chem; 2019 Mar; 294(10):3772-3782. PubMed ID: 30635402
[TBL] [Abstract][Full Text] [Related]
16. WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase II alpha leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells.
Murley JS; Constantinou A; Kamath NS; Grdina DJ
Cell Prolif; 1997; 30(6-7):283-94. PubMed ID: 9451419
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase II catalyzes a mitotic phosphorylation on threonine 1342 of human DNA topoisomerase IIalpha, which is recognized by the 3F3/2 phosphoepitope antibody.
Daum JR; Gorbsky GJ
J Biol Chem; 1998 Nov; 273(46):30622-9. PubMed ID: 9804834
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the C-terminal domain of yeast topoisomerase II by casein kinase II affects DNA-protein interaction.
Dang Q; Alghisi GC; Gasser SM
J Mol Biol; 1994 Oct; 243(1):10-24. PubMed ID: 7932731
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
Chen M; Beck WT
Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726
[TBL] [Abstract][Full Text] [Related]
20. Human topoisomerase II alpha is phosphorylated in a cell-cycle phase-dependent manner by a proline-directed kinase.
Wells NJ; Hickson ID
Eur J Biochem; 1995 Jul; 231(2):491-7. PubMed ID: 7635160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
